WO2002102353A1 - Process for producing stable enteric sugar-coated tablet - Google Patents

Process for producing stable enteric sugar-coated tablet Download PDF

Info

Publication number
WO2002102353A1
WO2002102353A1 PCT/JP2002/005950 JP0205950W WO02102353A1 WO 2002102353 A1 WO2002102353 A1 WO 2002102353A1 JP 0205950 W JP0205950 W JP 0205950W WO 02102353 A1 WO02102353 A1 WO 02102353A1
Authority
WO
WIPO (PCT)
Prior art keywords
coated
sugar
enteric
water
coating
Prior art date
Application number
PCT/JP2002/005950
Other languages
French (fr)
Japanese (ja)
Inventor
Hideyoshi Kobe
Yoichi Onuki
Tetsuo Kaneko
Katsumi Imamori
Original Assignee
Ssp Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ssp Co., Ltd. filed Critical Ssp Co., Ltd.
Priority to KR1020037016223A priority Critical patent/KR100861444B1/en
Publication of WO2002102353A1 publication Critical patent/WO2002102353A1/en
Priority to HK04106502A priority patent/HK1063727A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • A61K9/2826Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating

Definitions

  • the present invention relates to a method for producing a stable enteric-coated sugar-coated tablet, and more particularly to a method for producing an enteric-coated sugar-coated tablet which prevents discoloration and puncture of the sugar-coated tablet with time.
  • composition and formulation of the sugar-coating layer in sugar-coated tablets are diverse, and are often unknown and not yet clarified.
  • a film layer, a sub-coating layer, and a smoothing layer are generally formed sequentially on a central tablet to further prevent moisture penetration. It is manufactured by forming a layer of sucrose and finally glazing it with wax.
  • Sugar-coating operations are generally sub-coated to give the core tablets roundness (usually gelatin, gum arabic powder, aqueous solution of sucrose as sugar-coating solution, precipitated calcium carbonate as a spraying agent, a mixture of talc, sucrose and gum arabic powder).
  • enteric-coated sugar-coated tablets are coated with an enteric polymer that dissolves in the central tablet with an alcohol and then formed into a sugar-coated layer consisting of a sub-coating layer, a smoothing layer, a coloring layer, and a fixing layer.
  • enteric-coated products should be inactivated by gastric juice, such as enzymes, or stimulate the stomach, such as aspirin, or drugs that cause impaired digestion of the stomach. It is used for the preparation of drugs with certain properties.
  • an acidic and substantially insoluble but alkaline and soluble polymer material such as a cellulosic, biel or acrylic resin is used.
  • enteric coatings can be coated by dissolving in an organic solvent, or by using cellulosic polymers such as hydroxypropylmethylcellulose acetate succinate (HPMC AS) and propyloxymethylethylcellulose (CMEC). Is dispersed and coated in water. Latex-type water-based coating agents such as Eudragit L30D55 are often used. Recently, a method of dry-coating hydroxypropylmethylcellulose acetate succinate (HPMCAS) while spraying a liquid plasticizer has been developed.
  • HPMCAS hydroxypropylmethylcellulose acetate succinate
  • Japanese Patent Application Laid-Open No. 11-43430 discloses a method of adding a pigment binder to a coloring layer or a finishing layer to prevent peeling or cracking of a sugar coating layer;
  • Japanese Patent Application Laid-Open No. 7-55898 describes a method for enhancing the strength of a sugar-coated tablet by applying a film made of a high molecule soluble in both water and a lower alcohol to the sugar-coated tablet.
  • a method is described in which high-purity maltitol and pullulan are used in place of sucrose as sugar coating materials to increase the impact resistance and prevent cracking, breakage, and changes over time.
  • none of these methods is perfect.
  • Enteric polymer coating agents include cellulosic polymers such as cellulose acetate phthalate (CAP), hydroxypropyl methylcellulose phthalate (HPMCP), hydroxypropyl methylcellulose acetate succinate (HPMCAS), or carboxymethyl ester. Butyl cellulose (CMEC), etc .; vinyl polymers, for example, polyvinyl alcohol acetate phthalate (PV AP); acrylic polymers, for example, copolymers of methacrylic acid and ethyl acrylate (methacrylic acid copolymers L, S), etc. An acidic, substantially insoluble, but alkaline, soluble polymer material can be used.
  • a preferred enteric coating is HPMCAS.
  • Enteric coating can be performed by dry-coating a fine powdered enteric polymer material while spraying a liquid plasticizer onto uncoated tablets. Further, the enteric coating agent may be coated by dissolving it in an organic solvent, may be dispersed in water and coated, or may be a latex-type liquid.
  • the water-soluble polymer formed on the enteric polymer coating and the water-soluble polymer of the layer of Z or water-soluble saccharide include hydroxypropylcellulose (HPC), hydroxyfilm methylcellulose (HPMC), methylcell mouth, and force.
  • Water-soluble cellulosic polymers such as sodium ropoxymethylcellulose, hydroxyethylcellulose, and methylhydroxyethylcellulose; and pullulan and polyvinyl alcohol can be used. Of these, water-soluble cellulosic polymers, particularly hydroxypropylmethylcellulose (HPMC), are preferred.
  • sucrose mannitol
  • glucose mannitol
  • lactose etc.
  • water-soluble sugars be able to.
  • sucrose is preferred.
  • the above-mentioned water-soluble polymer and water-soluble saccharide may be used alone or in a mixture thereof, or a water-soluble saccharide may be used on a water-soluble polymer or a water-soluble saccharide may be used on a raw saccharide.
  • the hydrophilic polymer may be coated.
  • the layer thickness of the water-soluble polymer and / or water-soluble saccharide is 20 ⁇ m to 300 m, usually 22 to 300 wm, preferably 40 to 200 m, and particularly preferably. 4 8 to 15 ⁇ ⁇ .
  • the thickness of the layer is usually 40 to 300 m, preferably 48 to 200 m, and particularly preferably 60 to 150 m.
  • the thickness of the layer is usually 20 to 300 m, preferably 22 to 200 m, and particularly preferably 50 to 100 m. 1150 m. If it is less than 20 Am, sufficient puncture prevention and discoloration prevention effects cannot be obtained.
  • the total thickness of both layers may be in the above range.
  • the above-mentioned water-soluble polymer and water-soluble saccharide are each applied to an enteric-coated tablet in the form of an aqueous solution.
  • a saccharide such as sucrose
  • it is in the form of an aqueous solution of 10 to 80% (by weight)
  • a water-soluble polymer such as HPMC
  • an aqueous solution of 1 to 30% (by weight) is used.
  • the formation of the sugar coating layer after the formation of the water-soluble polymer and / or water-soluble saccharide layer is usually performed by a sugar coating operation including at least one of sub-coating, smoothing, coloring, and finishing, and then necessary. Polishing is performed accordingly. Particularly, when the diameter of the uncoated tablet is less than 7 bands, an enteric coating layer is formed, a water-soluble saccharide layer is formed, and a water-soluble polymer (especially, HPMC) layer is formed thereon.
  • a sugar-coated tablet can also be formed by forming a coloring layer using sucrose syrup. Example Next, the present invention will be described specifically with reference to examples, but the present invention is not limited thereto.
  • a central tablet (uncoated tablet) having the composition shown in Table 1 below was prepared using a 5.5R, 4.5R punch with a size of 55 nig per tablet.
  • the disintegrant hardness was 2.8 kg and the disintegration time (test solution: water) was 6 to 8 minutes.
  • the enteric-coated film tablets prepared in Reference Example 1 were coated with a 65% sucrose syrup at 5 mg / tablet using a ventilated pan-coating device (manufactured by Heiko Ichiyuichi 48 Freund Corporation). A m layer of sucrose was formed. Further, a smoothing layer of 35 mg per tablet was formed with an aqueous suspension composed of 10% of kaolin, 10% of calcium carbonate, 5% of talc, 5% of titanium oxide, 4% of arabic gum powder and 40% of sucrose. Finally, a coloring layer of 5 mg per tablet was formed using 65% sucrose syrup to which an evening dye was added, and the mixture was glossed with wax to obtain enteric-coated sugar-coated tablets.
  • the enteric-coated film tablets prepared in Reference Example 1 were sucrose 9 mg, film thickness 86 with 65% sucrose syrup using a ventilated pan-coating machine (Hikako Ichiyo 48, manufactured by Freund Corporation). Was formed. Further, a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain enteric-coated sugar-coated tablets.
  • Example 3
  • the enteric-coated film tablet produced in Reference Example 1 was Using Coater 48, Freund Sangyo Co., Ltd.), a film having a thickness of 124 mg was formed with sucrose 13 mg with syrup of 65% sucrose. Further, an enteric-coated sugar-coated tablet was obtained by forming and smoothing a smoothing layer and a coloring layer in the same manner as in Example 1.
  • Example 4
  • 6% hydroxypropyl methylcellulose (HPMC) (TC-5R Shin-Etsu Chemical Co., Ltd.) was applied to the enteric-coated film tablet prepared in Reference Example 1 using a ventilated pan coating machine (Hi-Ko Yuichi 48 type, Freund Sangyo Co., Ltd.).
  • a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain enteric-coated sugar-coated tablets.
  • 6% hydroxypropyl methylcellulose (TC-5R Shin-Etsu Chemical Co., Ltd.) was applied to the enteric-coated film tablet manufactured in Reference Example 1 using a ventilated pan-coating device (Hikko Itsuya- 48, manufactured by Freund Corporation).
  • a water-soluble film having a thickness of 52 im and a thickness of 52 mg was prepared from an aqueous solution of hydroxypropyl propylmethylcellulose (7 mg). Further, a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain enteric-coated sugar-coated tablets.
  • the enteric-coated film tablet prepared in Reference Example 1 was applied to a sucrose syrup of 65% with a sucrose of 6% and a film thickness of 57 m using a ventilated pan-coating device (Hachiko Co., Ltd., type 48 Freund Corporation). Then, a 10% aqueous solution of hydroxypropylmethylcellulose (75 mg in thickness) was formed with a 6% aqueous solution of hydroxypropylmethylcellulose (TC-15R manufactured by Shin-Etsu Chemical Co., Ltd.). Lastly, a 5% per-pill coating layer was formed with 65% sucrose syrup to which an evening dye had been added, and the tablets were glossed to give enteric-coated sugar-coated tablets.
  • the enteric-coated film tablets prepared in Reference Example 1 were applied to a 10% calcium carbonate, 5% talc, 5% titanium oxide, and 5% titanium oxide by using a ventilated pan coating machine (manufactured by Hikko Yuichi 48 Freund Corporation).
  • An aqueous suspension composed of 4% of rubber powder and 40% of sucrose formed a smoothing layer of 35 mg per tablet.
  • a coloring layer of 5 mg per tablet was formed with 65% sucrose syrup to which a tar dye had been added, and the tablets were glossed to give enteric-coated sugar-coated tablets.
  • the enteric film tablets prepared in Reference Example 1 were applied to a 65% sucrose syrup using a ventilated pan-coating machine (Hicoater 48, Freund Corporation) to produce 2 mg of sucrose and a film thickness of 19 m. Was formed. Further, a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain enteric-coated sugar-coated tablets. Comparative Example 3
  • 6% hydroxypropyl methylcellulose (TC-15R Shin-Etsu Chemical Co., Ltd.) was applied to the enteric-coated film tablets prepared in Reference Example 1 using a ventilated pan coating machine (Hachikoa 48 type, Freund Sangyo Co., Ltd.). 2) Hydroxypropyl methylcellulose 2 mg, 15 m thick water-soluble film layer was formed with the aqueous solution. Further, a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain an enteric sugar-coated tablet.
  • the enteric-coated sugar tablets obtained in Examples 1 to 8 and Comparative Examples 1 to 3 were stored at 50 ° C, and punctures and appearance changes of the dragees after one month were observed. The results are shown in Table 2.
  • indicates a value obtained by measuring a sample at 50 ° C for one month using a color difference meter SQ2000 (manufactured by Nippon Denshoku Industries Co., Ltd.) at the time of manufacture of each sample.
  • the present invention by coating a water-soluble polymer and / or a water-soluble saccharide on an enteric film, it becomes possible to produce a stable enteric-coated sugar-coated tablet without discoloration and puncture of the sugar-coated tablet.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

A process for producing a stable enteric sugar-coated tablet, characterized by coating an uncoated tablet with an enteric polymer, subsequently forming a 20 to 300 μm-thick layer made of a water-soluble polymer and/or water-soluble saccharide, and then forming a sugar coating. Thus, an enteric sugar-coated tablet can be produced which is stable and in which the sugar coating neither discolors nor punctures nor cracks.

Description

明 細 書 安定な腸溶性糖衣錠の製造法 技術分野  Description Manufacturing method for stable enteric-coated sugar-coated tablets
本発明は、 安定な腸溶性糖衣錠の製造法に関するもので、 特に経時的な糖衣錠 の変色及ぴパンクを防止した腸溶性糖衣錠の製造法に関するものである。 背景技術  The present invention relates to a method for producing a stable enteric-coated sugar-coated tablet, and more particularly to a method for producing an enteric-coated sugar-coated tablet which prevents discoloration and puncture of the sugar-coated tablet with time. Background art
糖衣錠における糖衣層の構成と処方は多種多様であり、 ノゥハウ化されて明ら かにされていないことが多いが、 「医薬品のコーティング」 (日本工業技術連盟 The composition and formulation of the sugar-coating layer in sugar-coated tablets are diverse, and are often unknown and not yet clarified.
) や、 「医薬品開発基礎講座 1 8製剤工学」 (地人書館) によれば、 概ね中心錠 の上にフィルム層、 サブコーティング層、 スムージング層を順次形成し、 さらに 水分の透過を防ぐ緻密なショ糖の層を形成し、 最後にヮックス類で艷出しするこ とにより製造される。 ) And the “Pharmaceutical Development Course 18 Pharmaceutical Engineering” (Jinjinshokan), a film layer, a sub-coating layer, and a smoothing layer are generally formed sequentially on a central tablet to further prevent moisture penetration. It is manufactured by forming a layer of sucrose and finally glazing it with wax.
糖衣操作は一般に、 中心錠に丸みを与えるためのサブコーティング (通例、 糖 衣液としてゼラチン、 アラビアゴム末、 白糖の水溶液、 散布剤としては沈降炭酸 カルシウム、 タルク、 白糖及びアラビアゴム末の混合物) 、 表面を滑らかにする ためのスムージング (通例、 糖衣液としてゼラチン、 アラビアゴム末、 白糖の水 溶液に沈降炭酸カルシウムあるいはタルクを加えたもの) 、 さらに滑らかで緻密 な着色層を作るためのカラーリング (通例、 着色剤及びゼラチンを加えた単シロ ップ液を淡色のものから始め漸次濃厚色液を用いる) 、 仕上げのフィニシング ( 通例、 着色剤を加えた単シロップ液) 、 及びつや出しのポリシング (通例、 白ろ う又はカルナウパロウ) からなる。 これらの各操作は糖衣液 (サブコーティング では適量の散布剤を混ぜる) を交互に繰り返し被覆することにより行われる。 糖 衣層の通気性 ·浸透性の抑制効果は、 白糖結晶からなる緻密なカラーリング層に 依存している。 Sugar-coating operations are generally sub-coated to give the core tablets roundness (usually gelatin, gum arabic powder, aqueous solution of sucrose as sugar-coating solution, precipitated calcium carbonate as a spraying agent, a mixture of talc, sucrose and gum arabic powder). , Smoothing to make the surface smooth (usually a solution of gelatin, gum arabic, or aqueous sugar solution with precipitated calcium carbonate or talc as a sugar coating liquid), and coloring to create a smoother and more dense colored layer (Usually, a simple syrup containing a colorant and gelatin is used, starting with a light color and gradually increasing in density.) Finishing (usually a single syrup containing a colorant), and polishing (polishing) It usually consists of white wax or Carnauparo. Each of these operations is performed by alternately and repeatedly coating a sugar coating liquid (in sub-coating, mix an appropriate amount of a spraying agent). The breathability and permeability of the sugar coating layer are reduced by the dense coloring layer made of sugar crystals. Depends.
一般に腸溶性の糖衣錠は、 中心錠にアル力リで溶解する腸溶性高分子をコ一テ イングした後、 サブコーティング層、 スムージング層、 カラ一リング層及びフィ 二シング層からなる糖衣層を形成して製造する。 腸溶性製剤は、 酵素類のように 胃液によって失活するか又は効果を低減する薬剤やアスピリンなどのように胃を 刺激したり、 胃の消化作用の障害を招く薬剤や腸内濃度を高める必要のある薬剤 の製剤に用いられる。  In general, enteric-coated sugar-coated tablets are coated with an enteric polymer that dissolves in the central tablet with an alcohol and then formed into a sugar-coated layer consisting of a sub-coating layer, a smoothing layer, a coloring layer, and a fixing layer. To manufacture. Enteric-coated products should be inactivated by gastric juice, such as enzymes, or stimulate the stomach, such as aspirin, or drugs that cause impaired digestion of the stomach. It is used for the preparation of drugs with certain properties.
腸溶性コーティング剤としては、 セルロース系、 ビエル系又はアクリル系等の、 酸性で実質的に不溶性であるがアルカリ性にて溶解性の高分子材料が使われてい る。 これらの腸溶性コ一ティング剤は、 有機溶媒に溶解してコーティングするか、 ヒドロキシプロピルメチルセルロースアセテートサクシネート (H P MC A S ) 、 力ルポキシメチルェチルセルロース ( CM E C) のようなセルロース系高分子は 水に分散してコーティングされている。 また、 オイドラギット L 3 0 D 5 5のよ うにラテックスタイプの水系コーティング剤を使用することも多い。 また、 最近 では、 ヒドロキシプロピルメチルセルロースアセテートサクシネート (H P M C A S ) を液状の可塑剤を噴霧しながら乾式コーティングする方法も開発されてい る。  As the enteric coating agent, an acidic and substantially insoluble but alkaline and soluble polymer material such as a cellulosic, biel or acrylic resin is used. These enteric coatings can be coated by dissolving in an organic solvent, or by using cellulosic polymers such as hydroxypropylmethylcellulose acetate succinate (HPMC AS) and propyloxymethylethylcellulose (CMEC). Is dispersed and coated in water. Latex-type water-based coating agents such as Eudragit L30D55 are often used. Recently, a method of dry-coating hydroxypropylmethylcellulose acetate succinate (HPMCAS) while spraying a liquid plasticizer has been developed.
しかし従来の糖衣錠は、 ひび割れやパンク及び色調の経時変化を起こしやすい 等の問題点があった。 これらの問題は主として、 サブコーティング層、 スムージ ング層の糖衣の各層形成が、 ゼラチン、 アラビアゴム末、 ショ糖、 沈降炭酸カル シゥム、 カオリン、 タルクなどを水に溶解又は分散した糖衣液を素錠に添加する 工程と乾燥する工程とを交互に繰り返し被覆する工程から成るが、 この糖衣操作 中で、 糖衣液中の水分が中心錠に若干侵入することが避けられず、 しかも糖衣層 の最後の層であるカラ一リング層は水蒸気の透過性が極めて低いため、 外部から の水蒸気の遮断は完全にするが中心錠に侵入した水分を放出することができず、 中心錠が水分に不安定な薬物の場合、 薬剤の分解を促進することになる、 という ことに起因する。 また、 このことが糖衣錠のパンクやひび割れ、 変色の原因にも なる。 特に、 水系コ一ティング及び乾式コーティングでは可塑剤を多く使用する ため、 これらのコ一ティング剤で腸溶性の糖衣錠を製造した場合、 可塑剤の影響 も加わり、 さらに糖衣錠のひび割れ、 パンクや変色といった問題が生じることに なる。 However, conventional sugar-coated tablets have problems such as easy occurrence of cracks, punctures, and changes in color tone over time. These problems are mainly caused by the sugar coating of the sub-coating layer and the smoothing layer, which consist of gelatin, gum arabic powder, sucrose, precipitated calcium carbonate, kaolin, talc, etc. In this sugar-coating operation, it is unavoidable that some of the water in the sugar-coating liquid penetrates into the central tablet, and the last step of the sugar-coating layer. The coloring layer, which is a layer, has a very low water vapor permeability, so it completely blocks water vapor from the outside, but cannot release the moisture that has entered the central tablet, making the central tablet unstable to moisture. In the case of drugs, it will accelerate the degradation of the drug Due to that. This also causes punctures, cracks and discoloration of dragees. In particular, since water-based coatings and dry coatings use a large amount of plasticizers, the production of enteric-coated sugar-coated tablets with these coating agents is also affected by the plasticizer, and further causes the sugar-coated tablets to crack, puncture or discolor. Problems will arise.
この対策として、 サブコーティング層形成時の錠剤の乾燥を十分に実施するこ とや、 中心錠にあらかじめ防水用のフィルムをコ一ティングし、 その後サブコー ティング層形成以降の糖衣操作に移行する方法をとることも考えられる。 この防 水フィルムを形成する工程をプロテクティブコーティングと呼んでいるが、 使用 するフィルムは、 水分に対してバリアー性のものである必要があるため、 セラッ クゃ水に不溶なコーティング剤などがよく使用される。 そのためフィノレムの厚さ が直接錠剤の崩壊性 ·溶出性に影響を及ぼすため、 フィルム厚さの制御に注意が 必要である等の難点があり、 糖衣錠のひび割れ、 パンク、 変色の防止策としては 完全なものとは言い難い。  As a countermeasure, there is a method of sufficiently drying the tablet when forming the sub-coating layer, a method of coating the center tablet with a waterproof film in advance, and then shifting to the sugar coating operation after the formation of the sub-coating layer. It is also possible to take. The process of forming this waterproof film is called protective coating.Since the film used must have a barrier property against moisture, it is often used with a coating agent that is insoluble in water. Is done. As a result, the thickness of finolem directly affects the disintegration and dissolution properties of tablets, so that attention must be paid to the control of the film thickness.This is a perfect measure to prevent cracking, puncturing and discoloration of dragees. It's hard to say.
また、 特開平 1 1一 4 3 4 3 0号には、 カラ一リング層やフィニシング層にピ グメントゃ結合剤を添加して糖衣層の剥離やひび割れを防止する方法が;特開平 1 1 - 1 1 6 4 6 7号には、 糖衣錠に水及び低級アルコールの双方に可溶性の高 分子から成る膜を施すことにより糖衣錠の強度を高める方法が;特開平 7— 5 5 8 9 8号には、 糖衣材料としてショ糖の代わりに高純度のマルチトールとプルラ ンを使用して耐衝撃性を高め、 ひび割れ、 破損、 経時的な変化を防止する方法が、 それぞれ記載されている。 しかしながら、 いずれの方法でも完璧な方法とは言い 難い。  Japanese Patent Application Laid-Open No. 11-43430 discloses a method of adding a pigment binder to a coloring layer or a finishing layer to prevent peeling or cracking of a sugar coating layer; Japanese Patent Application Laid-Open No. 7-55898 describes a method for enhancing the strength of a sugar-coated tablet by applying a film made of a high molecule soluble in both water and a lower alcohol to the sugar-coated tablet. A method is described in which high-purity maltitol and pullulan are used in place of sucrose as sugar coating materials to increase the impact resistance and prevent cracking, breakage, and changes over time. However, none of these methods is perfect.
従って、 経時的な糖衣錠の変色及び糖衣錠のパンクのない、 安定な腸溶性の糖 衣錠の製造方法が強く求められていた。 発明の開示 本発明は、 素錠に腸溶性高分子をコ一ティングした後、 水溶性高分子及び Z又 は水溶性糖類から成る膜厚 20〜300 mの層を形成し、 次いで糖衣層を形成 することを特徴とする、 腸溶性糖衣錠の製造法である。 発明を実施するための最良の形態 Accordingly, there has been a strong demand for a method for producing a stable enteric-coated sugar-coated tablet without discoloration of the sugar-coated tablet over time and puncture of the sugar-coated tablet. Disclosure of the invention In the present invention, after coating an enteric polymer on an uncoated tablet, a 20-300 m-thick layer composed of a water-soluble polymer and Z or a water-soluble saccharide is formed, and then a sugar coating layer is formed. A method for producing an enteric-coated sugar-coated tablet, characterized by the following: BEST MODE FOR CARRYING OUT THE INVENTION
腸溶性高分子コ一ティング剤としては、 セルロース系高分子、 例えばセル口一 スアセテートフタレート (CAP) 、 ヒドロキシプロピルメチルセルロースフタ レート (HPMCP) 、 ヒドロキシプロピルメチルセルロースアセテートサクシ ネート (HPMCAS) 、 又はカルボキシメチルェチルセルロース (CMEC) 等;ビニル系高分子、 例えばポリビエルアルコールアセテートフタレート (PV AP) ;アクリル系高分子、 例えばメタアクリル酸とアクリル酸ェチルの共重合 体 (メタアクリル酸コポリマー L、 S) 等、 酸性で実質的に不溶性であるがアル カリ性にて溶解性の高分子材料が使用できる。 好ましい腸溶性コーティング剤は HPMCASである。  Enteric polymer coating agents include cellulosic polymers such as cellulose acetate phthalate (CAP), hydroxypropyl methylcellulose phthalate (HPMCP), hydroxypropyl methylcellulose acetate succinate (HPMCAS), or carboxymethyl ester. Butyl cellulose (CMEC), etc .; vinyl polymers, for example, polyvinyl alcohol acetate phthalate (PV AP); acrylic polymers, for example, copolymers of methacrylic acid and ethyl acrylate (methacrylic acid copolymers L, S), etc. An acidic, substantially insoluble, but alkaline, soluble polymer material can be used. A preferred enteric coating is HPMCAS.
腸溶性コーティングは、 液体状の可塑剤を素錠に噴霧しながら微粉末状の腸溶 性高分子材料を乾式コーティングすることにより行うことができる。 さらに、 腸 溶性コ一ティング剤を有機溶媒に溶解してコ一ティングするか、 水に分散してコ 一ティングするか、 あるいはラテックスタイプの液をコ一ティングしてもよい。 腸溶性高分子コーティング上に形成する水溶性高分子及び Z又は水溶性糖類の 層の水溶性高分子としては、 ヒドロキシプロピルセルロース (HPC) 、 ヒドロ キシフィルムメチルセルロース (HPMC) 、 メチルセル口一ス、 力ルポキシメ チルセルロースナトリウム、 ヒドロキシェチルセルロース、 メチルヒドロキシェ チルセルロース等の水溶性セルロース系高分子;及びプルラン、 ポリビニルアル コールなどを使用することができる。 これらのうち、 水溶性セルロース系高分子、 特にヒドロキシプロピルメチルセルロース (HPMC) が好ましい。  Enteric coating can be performed by dry-coating a fine powdered enteric polymer material while spraying a liquid plasticizer onto uncoated tablets. Further, the enteric coating agent may be coated by dissolving it in an organic solvent, may be dispersed in water and coated, or may be a latex-type liquid. Examples of the water-soluble polymer formed on the enteric polymer coating and the water-soluble polymer of the layer of Z or water-soluble saccharide include hydroxypropylcellulose (HPC), hydroxyfilm methylcellulose (HPMC), methylcell mouth, and force. Water-soluble cellulosic polymers such as sodium ropoxymethylcellulose, hydroxyethylcellulose, and methylhydroxyethylcellulose; and pullulan and polyvinyl alcohol can be used. Of these, water-soluble cellulosic polymers, particularly hydroxypropylmethylcellulose (HPMC), are preferred.
水溶性糖類としては、 ショ糖、 マンニトール、 ブドウ糖、 乳糖などを使用する ことができる。 これらのうち、 ショ糖が好ましい。 Use sucrose, mannitol, glucose, lactose, etc. as water-soluble sugars be able to. Of these, sucrose is preferred.
上記の水溶性高分子及び水溶性糖類は、 それぞれを単独で用いても、 両者を混 合したものを用いても、 あるいは水溶性高分子上に水溶性糖類を又は水溶 f生糖類 上に水溶性高分子をコ一ティングしてもよい。  The above-mentioned water-soluble polymer and water-soluble saccharide may be used alone or in a mixture thereof, or a water-soluble saccharide may be used on a water-soluble polymer or a water-soluble saccharide may be used on a raw saccharide. The hydrophilic polymer may be coated.
水溶性高分子及び/又は水溶性糖類の層の膜厚は、 2 0 ^m〜 3 0 0 m、 通 常 2 2〜3 0 0 w m、 好ましくは 4 0〜2 0 0 m、 特に好ましくは 4 8〜1 5 Ο ΠΙである。 詳しくは、 水溶性糖類単独の場合、 前記層の膜厚は通常 4 0〜3 0 0 m, 好ましくは 4 8〜2 0 0 m、 特に好ましくは 6 0〜: 1 5 0 mであ る。 水溶性高分子単独又は水溶性高分子と水溶性糖類との併用の場合、 前記層の 膜厚は通常 2 0〜3 0 0 m、 好ましくは 2 2〜2 0 0 m、 特に好ましくは 5 0〜1 5 0 mである。 2 0 Am未満では充分なパンク防止及び変色防止の効果 が得られない。 水溶性高分子の層と水溶性糖類の層を別個にコーティングする場 合は、 両者の層の膜厚の合計が上記範囲になるようにすればよい。  The layer thickness of the water-soluble polymer and / or water-soluble saccharide is 20 ^ m to 300 m, usually 22 to 300 wm, preferably 40 to 200 m, and particularly preferably. 4 8 to 15 ΠΙ ΠΙ. Specifically, when the water-soluble saccharide is used alone, the thickness of the layer is usually 40 to 300 m, preferably 48 to 200 m, and particularly preferably 60 to 150 m. In the case of a water-soluble polymer alone or a combination of a water-soluble polymer and a water-soluble saccharide, the thickness of the layer is usually 20 to 300 m, preferably 22 to 200 m, and particularly preferably 50 to 100 m. 1150 m. If it is less than 20 Am, sufficient puncture prevention and discoloration prevention effects cannot be obtained. When the water-soluble polymer layer and the water-soluble saccharide layer are separately coated, the total thickness of both layers may be in the above range.
上記の水溶性高分子及び水溶性糖類は、 それぞれ水溶液の形態で腸溶性コーテ イング錠剤上に塗布する。 例えば、 ショ糖等の糖類を用いた場合は 1 0〜 8 0 ( 重量) %の水溶液の形態で、 そして H P M C等の水溶性高分子を用いた場合は 1 〜3 0 (重量) %の水溶液の形態で用いることができる。  The above-mentioned water-soluble polymer and water-soluble saccharide are each applied to an enteric-coated tablet in the form of an aqueous solution. For example, when a saccharide such as sucrose is used, it is in the form of an aqueous solution of 10 to 80% (by weight), and when a water-soluble polymer such as HPMC is used, an aqueous solution of 1 to 30% (by weight) is used. Can be used in the form of
水溶性高分子及び/又は水溶性糖類の層を形成した後の糖衣層形成は、 通常、 サブコーティング、 スムージング、 カラ一リング及びフィニシングの 1種以上を 含む糖衣操作により行われ、 その後、 必要に応じてポリシング (艷出し) を行う。 特に素錠の径が 7匪以下では、 腸溶性コーティング層を形成させた後、 水溶性 糖類の層を形成し、 その上に水溶性高分子 (特に H PMC) の層を形成し、 最後 にショ糖のシロップを用いてカラーリング層を形成して糖衣錠とすることもでき る。 実施例 次に、 実施例を挙げて本発明を具体的に説明するが、 本発明はこれに限定され るものではない。 The formation of the sugar coating layer after the formation of the water-soluble polymer and / or water-soluble saccharide layer is usually performed by a sugar coating operation including at least one of sub-coating, smoothing, coloring, and finishing, and then necessary. Polishing is performed accordingly. Particularly, when the diameter of the uncoated tablet is less than 7 bands, an enteric coating layer is formed, a water-soluble saccharide layer is formed, and a water-soluble polymer (especially, HPMC) layer is formed thereon. A sugar-coated tablet can also be formed by forming a coloring layer using sucrose syrup. Example Next, the present invention will be described specifically with reference to examples, but the present invention is not limited thereto.
参考例 1 〔中心錠剤の作製〕 Reference Example 1 (Preparation of central tablet)
下記表 1に示す組成の中心錠剤 (素錠) を、 径 5. 5画、 4. 5Rの杵にて 1 錠あたり 55 nigで作製した。 その綻剤硬度は 2. 8 kgで、 崩壊時間 (試験液:水 ) は 6〜 8分であった。  A central tablet (uncoated tablet) having the composition shown in Table 1 below was prepared using a 5.5R, 4.5R punch with a size of 55 nig per tablet. The disintegrant hardness was 2.8 kg and the disintegration time (test solution: water) was 6 to 8 minutes.
この錠剤 4. 7 kgを通気式パンコーティング機器 (Hicoater HCT-48 フロイン ト産業 (株) 製) に仕込み、 吸気温度 50° (:、 品温 45°C、 回転数 16rpmで、 クェン酸トリェチル /グリセリン脂肪酸エステル (35Z20) の可塑剤液をス プレー速度 20 g/minで噴霧しながら、 ヒドロキシプロピルメチルセル口一ス アセテートサクシネート (商品名 A S— M F信越化学工業 (株) 製) /タルク比 (10/6) を均一に混合した粉体を 58 gノ iiiinで散布して乾式コーティング を行い、 1錠 67mgの腸溶性フィルム錠を得た。 4.7 kg of these tablets were charged into a ventilated pan coating machine (Hicoater HCT-48 Freund Sangyo Co., Ltd.), and the intake air temperature was 50 ° (product temperature: 45 ° C; Spraying a plasticizer solution of glycerin fatty acid ester (35Z20) at a spray rate of 20 g / min, hydroxypropylmethylcell mouth acetate succinate (trade name: AS—MF Shin-Etsu Chemical Co., Ltd.) / Talc ratio The powder obtained by uniformly mixing (10/6) was sprayed with 58 g of iiiin to perform dry coating to obtain 67 mg of an enteric film tablet per tablet.
表 1 table 1
(中心錠剤組成)  (Center tablet composition)
Figure imgf000008_0001
実施例 1
Figure imgf000008_0001
Example 1
参考例 1で製造した腸溶性フィルム錠に、 通気式パンコーティング機器 (ハイ コ一夕一 48型 フロイント産業 (株) 製) を用いて、 65%ショ糖シロップで 1錠あたり 5mg、 膜厚 48 mのショ糖の層 (皮膜) を形成した。 さらに、 カオ リン 10%、 炭酸カルシウム 10%、 タルク 5 %、 酸化チタン 5 %、 アラビアゴ ム末 4%及びショ糖 40 %よりなる水懸濁液で 1錠あたり 35mgのスムージング 層を形成した。 最後に、 夕一ル色素を添加した 65%ショ糖シロップを用いて 1 錠あたり 5mgのカラーリング層を形成し、 ワックスで艷出しをして腸溶性の糖衣 錠を得た。  The enteric-coated film tablets prepared in Reference Example 1 were coated with a 65% sucrose syrup at 5 mg / tablet using a ventilated pan-coating device (manufactured by Heiko Ichiyuichi 48 Freund Corporation). A m layer of sucrose was formed. Further, a smoothing layer of 35 mg per tablet was formed with an aqueous suspension composed of 10% of kaolin, 10% of calcium carbonate, 5% of talc, 5% of titanium oxide, 4% of arabic gum powder and 40% of sucrose. Finally, a coloring layer of 5 mg per tablet was formed using 65% sucrose syrup to which an evening dye was added, and the mixture was glossed with wax to obtain enteric-coated sugar-coated tablets.
実施例 2 Example 2
参考例 1で製造した腸溶性フィルム錠に、 通気式パンコーティング機器 ひ \ィ コ一夕一 48型 フロイント産業 (株) 製) を用いて 65%ショ糖のシロップで ショ糖 9mg、 膜厚 86 の皮膜を形成した。 さらに、 実施例 1と同様にスム一 ジング層及びカラ一リング層の形成、 艷出しをして、 腸溶性の糖衣錠を得た。 実施例 3  The enteric-coated film tablets prepared in Reference Example 1 were sucrose 9 mg, film thickness 86 with 65% sucrose syrup using a ventilated pan-coating machine (Hikako Ichiyo 48, manufactured by Freund Corporation). Was formed. Further, a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain enteric-coated sugar-coated tablets. Example 3
参考例 1で製造した腸溶性フィルム錠に、 通気式バンコ一ティング機器 (ハイ コ一ター 48型 フロイン卜産業 (株) 製) を用いて 65%ショ糖のシロップで ショ糖 13mg、 膜厚 124 の皮膜を形成した。 さらに、 実施例 1と同様にス ム一ジング層及びカラ一リング層の形成、 艷出しをして、 腸溶性の糖衣錠を得た, 実施例 4 The enteric-coated film tablet produced in Reference Example 1 was Using Coater 48, Freund Sangyo Co., Ltd.), a film having a thickness of 124 mg was formed with sucrose 13 mg with syrup of 65% sucrose. Further, an enteric-coated sugar-coated tablet was obtained by forming and smoothing a smoothing layer and a coloring layer in the same manner as in Example 1. Example 4
参考例 1で製造した腸溶性のフィルム錠に、 通気式パンコーティング機器 (ハ イコー夕一 48型 フロイント産業 (株) 製) を用いて 6%ヒドロキシプロピル メチルセルロース (HPMC) (TC-5 R 信越化学工業 (株) 製) 水溶液 でヒドロキシプロピルメチルセル口一ス 3mg、 膜厚 22 mの水溶性皮膜を形成 した。 さらに、 実施例 1と同様にスム一ジング層及びカラーリング層の形成、 艷 出しをして腸溶性の糖衣錠を得た。  6% hydroxypropyl methylcellulose (HPMC) (TC-5R Shin-Etsu Chemical Co., Ltd.) was applied to the enteric-coated film tablet prepared in Reference Example 1 using a ventilated pan coating machine (Hi-Ko Yuichi 48 type, Freund Sangyo Co., Ltd.). A water-soluble film with a thickness of 22 mg and a hydroxypropylmethyl cell opening of 3 mg was formed with an aqueous solution. Further, a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain enteric-coated sugar-coated tablets.
実施例 5 Example 5
参考例 1で製造した腸溶性フィルム錠に、 通気式パンコーティング機器 ひ ィ コ一夕—48型 フロイント産業 (株) 製) を用いて 6%ヒドロキシプロピルメ チルセルロース (TC-5 R 信越化学工業 (株) 製) 水溶液でヒドロキシプ 口ピルメチルセルロース 7 mg、 膜厚 52 imの水溶性皮膜を形成した。 さらに、 実施例 1と同様にスム一ジング層及びカラ一リング層の形成、 艷出しをして、 腸 溶性の糖衣錠を得た。 6% hydroxypropyl methylcellulose (TC-5R Shin-Etsu Chemical Co., Ltd.) was applied to the enteric-coated film tablet manufactured in Reference Example 1 using a ventilated pan-coating device (Hikko Itsuya- 48, manufactured by Freund Corporation). A water-soluble film having a thickness of 52 im and a thickness of 52 mg was prepared from an aqueous solution of hydroxypropyl propylmethylcellulose (7 mg). Further, a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain enteric-coated sugar-coated tablets.
実施例 6 Example 6
参考例 1で製造した腸溶性のフィルム錠に、 通気式バンコ一ティング機器 ひ、 イコーター 48型 フロイント産業 (株) 製) を用いて 6%ヒドロキシプロピル メチルセリレ口一ス (TC一 5 R 信越化学工業 (株) 製) 水溶液でヒドロキシ プロピルメチルセルロース 10mg、 膜厚 75 mの水溶性皮膜を形成した。 さら に、 実施例 1と同様にスム一ジング層及びカラ一リング層の形成、 艷出しをして 腸溶性の糖衣錠を得た。  6% hydroxypropyl methylcellulose mouth (TC-15R Shin-Etsu Chemical Co., Ltd.) was applied to the enteric-coated film tablet manufactured in Reference Example 1 using a ventilated banco-coating device (Ikoter 48, manufactured by Freund Industrial Co., Ltd.). A water-soluble film having a thickness of 75 m and a hydroxypropylmethylcellulose concentration of 10 mg was formed with an aqueous solution. Further, a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain enteric-coated sugar-coated tablets.
実施例 7 Example 7
参考例 1で製造した腸溶性のフイルム錠に、 通気式パンコ一 イコーター 48型 フロイント産業 (株) 製) を用いて 65%のショ糖のシロッ プでショ糖 3mg、 膜厚 28 mの層を形成し、 次に 6 %ヒドロキシプロピルメチ ルセルロース (TC一 5 R 信越化学工業 (株) 製) 水溶液でヒドロキシプロ ピルメチルセルロース 1 Omg、 膜厚 75. mの水溶性皮膜を形成した。 さらに、 最後に、 夕一ル色素を添加した 65%ショ糖シロップで 1錠あたり 5mgのカラ一 リング層を形成し、 ワックスで艷出しをして腸溶性の糖衣錠を得た。 In addition to the enteric film tablet produced in Reference Example 1, Using a coater made of 65% sucrose, a layer of 3 mg of sucrose and a thickness of 28 m was formed using an icoter 48 type Freund Sangyo Co., Ltd.), followed by 6% hydroxypropyl methylcellulose (TC-15R (Shin-Etsu Chemical Co., Ltd.) A water-soluble film having a thickness of 75 m was formed with an aqueous solution of hydroxypropylmethylcellulose (1 Omg). Finally, a coloring layer of 5 mg per tablet was formed with a 65% sucrose syrup to which an evening dye had been added, and the mixture was glossed with wax to obtain enteric-coated sugar-coated tablets.
実施例 8 Example 8
参考例 1で製造した腸溶性のフィルム錠に、 通気式パンコーティング機器 (八 イコーター 48型 フロイント産業 (株) 製) を用いて 65%のショ糖のシロッ プでショ糖 6mg、 膜厚 57 mの層を形成し、 次に 6 %ヒドロキシプロピルメチ ルセルロース (TC一 5 R 信越化学工業 (株) 製) 水溶液でヒドロキシプロ ピルメチルセルロース 10mg、 膜厚 75 mの水溶性皮膜剤層を形成した。 さら に、 最後に、 夕一ル色素を添加した 65%ショ糖シロップで 1錠あたり 5mgの力 ラーリング層を形成し、 ワックスで艷出しをして腸溶性の糖衣錠を得た。  The enteric-coated film tablet prepared in Reference Example 1 was applied to a sucrose syrup of 65% with a sucrose of 6% and a film thickness of 57 m using a ventilated pan-coating device (Hachiko Co., Ltd., type 48 Freund Corporation). Then, a 10% aqueous solution of hydroxypropylmethylcellulose (75 mg in thickness) was formed with a 6% aqueous solution of hydroxypropylmethylcellulose (TC-15R manufactured by Shin-Etsu Chemical Co., Ltd.). Lastly, a 5% per-pill coating layer was formed with 65% sucrose syrup to which an evening dye had been added, and the tablets were glossed to give enteric-coated sugar-coated tablets.
比較例 1 Comparative Example 1
参考例 1で製造した腸溶性のフィルム錠に、 通気式パンコーティング機器 (ハ イコー夕一 48型 フロイント産業 (株) 製) を用いて炭酸カルシウム 10%、 タルク 5 %、 酸化チタン 5 %、 アラビアゴム末 4%及びショ糖 40 %よりなる水 懸濁液で 1錠あたり 35mgのスム一ジング層を形成した。 次に、 タール色素を添 加した 65%ショ糖シロップで 1錠あたり 5mgのカラーリング層を形成し、 ヮッ クスで艷出しをして腸溶性の糖衣錠を得た。  The enteric-coated film tablets prepared in Reference Example 1 were applied to a 10% calcium carbonate, 5% talc, 5% titanium oxide, and 5% titanium oxide by using a ventilated pan coating machine (manufactured by Hikko Yuichi 48 Freund Corporation). An aqueous suspension composed of 4% of rubber powder and 40% of sucrose formed a smoothing layer of 35 mg per tablet. Next, a coloring layer of 5 mg per tablet was formed with 65% sucrose syrup to which a tar dye had been added, and the tablets were glossed to give enteric-coated sugar-coated tablets.
比較例 2 Comparative Example 2
参考例 1で製造した腸溶性のフィルム錠に、 通気式パンコーティング機器 (ハ イコーター 48型 フロイント産業 (株) 製) を用いて 65%のショ糖のシロッ プでショ糖 2mg、 膜厚 19 mの層を形成した。 さらに、 実施例 1と同様にスム 一ジング層及びカラ一リング層の形成、 艷出しをして、 腸溶性の糖衣錠を得た。 比較例 3 The enteric film tablets prepared in Reference Example 1 were applied to a 65% sucrose syrup using a ventilated pan-coating machine (Hicoater 48, Freund Corporation) to produce 2 mg of sucrose and a film thickness of 19 m. Was formed. Further, a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain enteric-coated sugar-coated tablets. Comparative Example 3
参考例 1で製造した腸溶性のフィルム錠に、 通気式パンコーティング機器 (八 イコーター 48型 フロイント産業 (株) 製) を用いて 6%のヒドロキシプロピ ルメチルセルロース (TC一 5 R 信越化学工業 (株) 製) 水溶液でヒドロキ シプロピルメチルセルロース 2 mg、 膜厚 1 5 mの水溶性皮膜層を形成した。 さ らに、 実施例 1と同様にスムージング層及びカラーリング層の形成、 艷出しをし て、 腸溶性の糖衣錠を得た。  6% hydroxypropyl methylcellulose (TC-15R Shin-Etsu Chemical Co., Ltd.) was applied to the enteric-coated film tablets prepared in Reference Example 1 using a ventilated pan coating machine (Hachikoa 48 type, Freund Sangyo Co., Ltd.). 2) Hydroxypropyl methylcellulose 2 mg, 15 m thick water-soluble film layer was formed with the aqueous solution. Further, a smoothing layer and a coloring layer were formed and glazed in the same manner as in Example 1 to obtain an enteric sugar-coated tablet.
試験例  Test example
実施例 1〜 8及び比較例 1〜 3で得られた腸溶性糖衣錠を 50 °Cの条件で保存 し、 1力月後の糖衣錠のパンク及び外観変化を観察した。 その結果を、 表 2に示 す。  The enteric-coated sugar tablets obtained in Examples 1 to 8 and Comparative Examples 1 to 3 were stored at 50 ° C, and punctures and appearance changes of the dragees after one month were observed. The results are shown in Table 2.
表 2  Table 2
パンク及び外観変化  Punk and appearance change
Figure imgf000011_0001
Figure imgf000011_0001
ΔΕは、 色差計 SQ2000 (日本電色工業 (株) 製) にて各検体の製造時を タ一ゲッ卜して 50°C、 1力月の検体を測定した値を示した。  ΔΕ indicates a value obtained by measuring a sample at 50 ° C for one month using a color difference meter SQ2000 (manufactured by Nippon Denshoku Industries Co., Ltd.) at the time of manufacture of each sample.
厶 E== 3以下:製造時と比較し、 変化なし  E == 3 or less: No change compared to the time of manufacture
厶 E= 3〜5 :製造時と比較し、 わずかに変化している ΔΕ=5〜10:製造時と比較し、 明らかに変化している 産業上の利用可能性 E = 3-5: slightly changed compared to the time of manufacture ΔΕ = 5 ~ 10 : Compared to the time of manufacture, clearly changing Industrial applicability
本発明によれば、 腸溶性皮膜上に水溶性高分子及び/又は水溶性糖類をコーテ ィングすることにより、 糖衣錠の変色及びパンクなどのない安定な腸溶性糖衣錠 を製造することが可能となる。  According to the present invention, by coating a water-soluble polymer and / or a water-soluble saccharide on an enteric film, it becomes possible to produce a stable enteric-coated sugar-coated tablet without discoloration and puncture of the sugar-coated tablet.

Claims

請求 の範 囲 The scope of the claims
1 . 素錠に腸溶性高分子をコーティングした後、 水溶性高分子及び/又は水溶 性糖類から成る膜厚 2 0〜3 0 0 mの層を形成し、 次いで糖衣層を形成するこ とを特徴とする、 腸溶性糖衣錠の製造法。 1. After coating the uncoated tablet with the enteric polymer, a layer of water-soluble polymer and / or water-soluble saccharide having a thickness of 20 to 300 m is formed, and then a sugar coating layer is formed. A method for producing an enteric-coated sugar-coated tablet.
2. 水溶性高分子及び/又は水溶性糖類の層がヒドロキシプロピルメチルセル ロースを含む、 請求項 1記載の腸溶性糖衣錠の製造法。  2. The method for producing an enteric-coated sugar-coated tablet according to claim 1, wherein the layer of the water-soluble polymer and / or the water-soluble saccharide contains hydroxypropylmethylcellulose.
3. 素錠への腸溶性高分子のコーティングが、 素錠に可塑剤を噴霧しながら微 粉末状の腸溶性高分子を散布被覆する乾式コーティング法によることを特徴とす る、 請求項 1又は 2記載の腸溶性糖衣錠の製造法。  3. The coating of the enteric polymer on the uncoated tablet is performed by a dry coating method in which the uncoated tablet is spray-coated with a finely powdered enteric polymer while spraying a plasticizer. 2. The method for producing an enteric-coated sugar-coated tablet according to 2.
PCT/JP2002/005950 2001-06-15 2002-06-14 Process for producing stable enteric sugar-coated tablet WO2002102353A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020037016223A KR100861444B1 (en) 2001-06-15 2002-06-14 Process for producing stable enteric sugar-coated tablet
HK04106502A HK1063727A1 (en) 2001-06-15 2004-08-30 Process for producing stable enteric sugar-coated tablet

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001181989A JP4856323B2 (en) 2001-06-15 2001-06-15 Method for producing stable enteric-coated sugar-coated tablets
JP2001-181989 2001-06-15

Publications (1)

Publication Number Publication Date
WO2002102353A1 true WO2002102353A1 (en) 2002-12-27

Family

ID=19022169

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/005950 WO2002102353A1 (en) 2001-06-15 2002-06-14 Process for producing stable enteric sugar-coated tablet

Country Status (6)

Country Link
JP (1) JP4856323B2 (en)
KR (1) KR100861444B1 (en)
CN (1) CN1243539C (en)
HK (1) HK1063727A1 (en)
TW (1) TWI317290B (en)
WO (1) WO2002102353A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4759905B2 (en) * 2002-09-10 2011-08-31 大正製薬株式会社 Dragees
JP2005298373A (en) * 2004-04-08 2005-10-27 Kyowa Hakko Kogyo Co Ltd Sugar-coated tablet containing water absorptive amino acid
CN101646421A (en) 2007-04-26 2010-02-10 卫材R&D管理有限公司 The preparation method of tablet

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49132218A (en) * 1973-04-20 1974-12-18
EP0745383A2 (en) * 1995-06-02 1996-12-04 Shin-Etsu Chemical Co., Ltd. An enteric preparation coated with a non-solvent enteric coating agent using a liquid plasticizer
JP2000169365A (en) * 1998-12-10 2000-06-20 Taisho Pharmaceut Co Ltd Sugar-coated tablet
JP2000355540A (en) * 1998-04-20 2000-12-26 Eisai Co Ltd Stabilized composition comprising benzimidazole-based compound
JP2001026534A (en) * 1999-07-09 2001-01-30 Taisho Pharmaceut Co Ltd Sugar-coated solid composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49132218A (en) * 1973-04-20 1974-12-18
EP0745383A2 (en) * 1995-06-02 1996-12-04 Shin-Etsu Chemical Co., Ltd. An enteric preparation coated with a non-solvent enteric coating agent using a liquid plasticizer
JP2000355540A (en) * 1998-04-20 2000-12-26 Eisai Co Ltd Stabilized composition comprising benzimidazole-based compound
JP2000169365A (en) * 1998-12-10 2000-06-20 Taisho Pharmaceut Co Ltd Sugar-coated tablet
JP2001026534A (en) * 1999-07-09 2001-01-30 Taisho Pharmaceut Co Ltd Sugar-coated solid composition

Also Published As

Publication number Publication date
KR20040007695A (en) 2004-01-24
HK1063727A1 (en) 2005-01-14
TWI317290B (en) 2009-11-21
CN1243539C (en) 2006-03-01
KR100861444B1 (en) 2008-10-02
CN1509167A (en) 2004-06-30
JP2002370971A (en) 2002-12-24
JP4856323B2 (en) 2012-01-18

Similar Documents

Publication Publication Date Title
US4001390A (en) Method of coating pharmaceutical solid dosage forms
US3835221A (en) Orally administrable drug dosage form having delayed action
US20040182283A1 (en) Pearlescent film coating systems and substrates coated therewith
US3576663A (en) Coated tablet
EP0501553A1 (en) A method of highlighting intagliations in tablets
JPH07103047B2 (en) Polydextrose-based coating for aqueous film coating of pharmaceutical, food and confectionery products
AU784433B2 (en) Method for coating pharmaceutical dosage forms
AU2007224129A1 (en) Oral controlled release formulation for sedative and hypnotic agents
JPS6229515A (en) Method for film-coating of hard capsule
HU202402B (en) Coloured coated concave subjects and process for producing them
US3524756A (en) Process of coating tablets with alternate tacky and non-tacky layers
CN102164576B (en) Smooth, high solids tablet coating composition
RU2593771C2 (en) Enteric-coated tablet
WO2002102353A1 (en) Process for producing stable enteric sugar-coated tablet
Porter Coating of tablets and multiparticulates
JP4016128B2 (en) Light-resistant epinastine hydrochloride film-coated tablets
Miller et al. Aqueous polymeric film coating
AU690680B2 (en) A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating
IE56151B1 (en) Tablet formulation
PL202884B1 (en) Acrylic enteric coating compositions
US20110244035A1 (en) Dosage Forms
US3282790A (en) Enteric coated tablet
CN113165338A (en) Smooth high solids film coating compositions comprising water soluble cellulose ethers and processes for making same
JPH05507937A (en) Method of manufacturing gelatin coated drug
JP4772327B2 (en) Pharmaceutical coating agent modifier

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 028098153

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 1020037016223

Country of ref document: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase